Tocilizumab, an IL6-receptor antibody, proved effective as adjuvant therapy for cytokine storm induced by severe infection in patients with hematologic malignancy

Patients with hematological malignancies who experience severe infections are at risk of developing dangerous complications due to excessive inflammatory cytokines. To improve the prognosis, it is crucial to identify better ways to manage the systemic inflammatory storm after infection. In this stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Bingjie, Wang, Qian, Liang, Zeyin, Yin, Yue, Wang, Lihong, Wang, Qingya, Li, Yuan, Ou, Jinping, Ren, Hanyun, Dong, Yujun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981444/
https://www.ncbi.nlm.nih.gov/pubmed/36864209
http://dx.doi.org/10.1007/s00277-023-05146-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981444/
https://www.ncbi.nlm.nih.gov/pubmed/36864209
http://dx.doi.org/10.1007/s00277-023-05146-0

Ejemplares similares